Mesoblast (MESO) Tops Q4 EPS Expectations

August 25, 2016 7:53 AM EDT
Get Alerts MESO Hot Sheet
Trade MESO Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Mesoblast (NASDAQ: MESO) reported Q4 EPS of $0.13, $0.20 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $26.9 million versus the consensus estimate of $4.2 million.

Mesoblast ended FY16 with cash reserves of US$80.9 million. The Company reduced its annual operating and investing cash outflows by 15% (US$16.4 million) to US$89.7 million for FY16 in comparison with the prior financial year. Additionally, Mesoblast outlined cost-cutting measures to further reduce cash burn by up to US$25 million in the year ended 30 June 2017 (FY17) in order to absorb the incremental costs of the heart failure program.

For earnings history and earnings-related data on Mesoblast (MESO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment